Jonathan Darrow
Jonathan Darrow, S.J.D., LL.M., J.D., M.B.A
Assistant Professor of Medicine, Harvard Medical School
Faculty Member of the Center for Bioethics

Jonathan J. Darrow, SJD, LLM, JD, MBA, BS. Dr. Darrow is an Assistant Professor at Harvard Medical School, where he focuses on the intersection of law, innovation, and pharmaceuticals. He received his research doctorate (SJD) in pharmaceutical policy from Harvard University, where he completed an LL.M. program in intellectual property (waived), as well as degrees in genetics (BS), law (JD), and business (MBA) from Cornell University, Duke University, and Boston College. He has served as a senior law clerk at the U.S. Court of Appeals for the Federal Circuit, worked in private law practice at Cooley LLP and Wiley Rein LLP, taught on the faculties of four universities and for the World Intellectual Property Organization, authored several law textbooks, supported the intellectual property divisions of WHO and WTO, and lectured widely on issues of innovation, intellectual property, and FDA regulation. His areas of bioethical interest include patient autonomy as part of pharmaceutical selection and use, disclosure of drug efficacy information in advertisements, physician and regulator conflicts of interest, and trade-offs that occur when insurance coverage is mandated for high-cost but low-value products.

Publications View
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.
Authors: Authors: Kesselheim AS, Darrow JJ, Kulldorff M, Brown BL, Mitra-Majumdar M, Lee CC, Moneer O, Avorn J.
Health Aff (Millwood)
View full abstract on Pubmed
Evidence Supporting the Value of Surgical Procedures: Can We Do Better?
Authors: Authors: Darrow JJ, Robertson CT, Kasoff WS.
Am Surg
View full abstract on Pubmed
Comparing Onset of Biosimilar Versus Generic Competition in the United States.
Authors: Authors: Beall RF, Ronksley PE, Wick J, Darrow JJ, Sarpatwari A, Kesselheim AS.
Clin Pharmacol Ther
View full abstract on Pubmed
Efficacy and costs of spinal muscular atrophy drugs.
Authors: Authors: Darrow JJ, Sharma M, Shroff M, Wagner AK.
Sci Transl Med
View full abstract on Pubmed
Drug Shortages and the Defense Production Act.
Authors: Authors: Raunig BL, Kesselheim AS, Darrow JJ.
Am J Public Health
View full abstract on Pubmed
Understanding when real world data can be used to replicate a clinical trial: A cross-sectional study of medications approved in 2011.
Authors: Authors: Fralick M, Bartsch E, Darrow JJ, Kesselheim AS.
Pharmacoepidemiol Drug Saf
View full abstract on Pubmed
Origins and Ownership of Remdesivir: Implications for Pricing.
Authors: Authors: Lee CC, Darrow JJ, Avorn J, Kesselheim AS.
J Law Med Ethics
View full abstract on Pubmed
Regulatory approval characteristics of antimicrobial versus non-antimicrobial products, 1984-2018: an evaluation of Food and Drug Administration flexibilities.
Authors: Authors: Darrow JJ, Najafzadeh M, Stefanini K, Kesselheim AS.
Lancet Infect Dis
View full abstract on Pubmed
Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs.
Authors: Authors: Darrow JJ, Chong JE, Kesselheim AS.
BMJ
View full abstract on Pubmed
Commentary: Expedited Regulatory Review of Low-Value Drugs.
Authors: Authors: Darrow JJ, Beall RF.
Healthc Policy
View full abstract on Pubmed